Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 11121 - 11140 of 44633
Advocacy Filings

FTC Staff Comment Before the Pennsylvania House of Representatives Regarding Proposed Legislation to Regulate Pre-Need Cemetery and Funeral Merchandise Sales

… FTC Staff Comment Before the Pennsylvania House of Representatives Regarding Proposed Legislation to Regulate Pre-Need Cemetery and Funeral Merchandise Sales Enviado por ccampos el Mar, 20/10/2015 - 14:05 …
Date
Matter Number
V150014
FTC staff submitted a comment, in response to a request from Pennsylvania State Representative Robert W. Godshall, on legislative proposals that would further regulate the pre-need sale of cemetery...
Related Release
FTC Staff Provides Comments to Pennsylvania General Assembly on Proposals Affecting Pre-Need Cemetery Sales
Cases and Proceedings

Pairsys, Inc.

… Pairsys, Inc. Pairsys, Inc. … Pairsys, Inc. …
Type of Action
Federal
Last Updated
FTC Matter/File Number
142 3099
X14 0066
Early Termination Notices

20160036: Terry Taylor; Swope Holdings, LLC

… 20160036: Terry Taylor; Swope Holdings, LLC HSR Early Termination Notice 20160036: Terry Taylor; Swope Holdings, LLC 20160036 Precision Cars of Louisville, LLC Sam …
Date
Acquiring Party
Terry Taylor
Acquired Party
Swope Holdings, LLC
Acquired Entities
Precision Cars of Louisville, LLC
Sam Swope Imports, LLC
Sam Swope Auto Group, LLC
Swope Development, LLC
Cases and Proceedings

Pfizer Inc./Hospira, Inc., In the Matter of

… Pfizer Inc./Hospira, Inc., In the Matter of Pfizer Inc./Hospira, Inc., In the Matter of Pfizer Inc. agreed to sell the rights and …

Pfizer Inc. agreed to sell the rights and assets related to four pharmaceutical products in order to settle FTC charges that its proposed $16 billion acquisition of Hospira, Inc. would likely be anticompetitive. Pfizer is one of the world’s largest drug companies and principally competes with Hospira in markets for certain sterile injectable pharmaceutical products. The order requires Pfizer to supply Alvogen with the clindamycin phosphate injection product for three years while Pfizer transfers the manufacturing technology to Alvogen or its designee. Pfizer also is required to provide transitional services to Alvogen to assist with establishing manufacturing capabilities and securing FDA approvals to market all of the divested products.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0074
Docket Number
C-4537
Displaying 11121 - 11140 of 44633
Return to top